Douglas K. Miller

Merck & Co., Inc., Rahway, NJ, USA (United States)

Papers

1

Total Citations

13

H-Index

1

About

Douglas K. Miller is a distinguished researcher whose work has significantly advanced the field of biochemical assay development, particularly in the context of inflammatory mediators. His primary research focus lies in the design and implementation of high-throughput, homogeneous fluorescent assays for quantifying bioactive lipids, with a major contribution being the creation of a novel method for measuring leukotriene B4 (LTB4)—a key pro-inflammatory molecule. This work, detailed in his most-cited paper from 2005, has garnered 13 citations, underscoring its utility in both basic and translational research. Miller’s assay offers a high-capacity, sensitive, and non-radioactive alternative to traditional techniques, enabling more efficient screening of LTB4 in complex biological samples. This innovation has implications for studying inflammatory diseases such as asthma and arthritis, as well as for drug discovery targeting leukotriene pathways. Beyond this landmark study, Miller’s broader contributions to analytical biochemistry have provided researchers with robust tools for lipid mediator analysis, facilitating deeper insights into immune signaling. His work exemplifies the critical role of method development in advancing biomedical science, making him a notable figure in the field of inflammation research.

Research Focus

Key Achievements

1
H-Index
1
Papers
13
Total Citations
13
Avg Citations/Paper
🏆 Most Cited Paper
Development of a high-capacity homogeneous fluorescent assay for the measurement of leukotriene B4
13 citations · 2005
📈 Most Prolific Year: 2005 (1 Papers)
🤝 Key Collaborators: 10
🏛 Institutions: Merck & Co., Inc., Rahway, NJ, USA (United States)

Top Papers

  1. 1

Key Collaborators

Contact & Links

Available for collaboration
Content generated · 13 days ago